AKT1 and lung adenocarcinoma: These two genes are known to affect the proliferation, immune evasion, and drug resistance of lung adenocarcinoma by disrupting cell adhesion and regulating signaling pathways such as PI3K/AKT and WNT/β-catenin (37–39).